![Pharis Mohideen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 390 781 $ al 31/07/2026
Pharis Mohideen is currently Chief Medical Officer at DBV Technologies SA since 2019.
Former positions include Chief Medical Officer at Millendo Therapeutics, Inc. from 2014 to 2019; Vice President-Clinical Development at Shionogi, Inc. from 2012 to 2014; Global Head-Clinical Program at Novartis Oncology, Inc. from 2008 to 2012; Senior Director at Novartis International AG from 2006 to 2008; Principal at Bristol Myers Squibb Co.; Chief Medical Officer at Millendo Therapeutics US, Inc.; and Assistant Professor-Medicine at the University of Hawai'i at Hilo.
Education includes undergraduate, graduate, and doctorate degrees from the University of Hawai'i at Hilo and graduate studies at Vanderbilt University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
DBV TECHNOLOGIES SA 0,05 % | 29/07/2026 | 144.531 ( 0,05 % ) | 390 781 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| DBV TECHNOLOGIES | Director Técnico/Científico/I+D | 22/07/2019 |
| Empresas | Cargo | Fin |
|---|---|---|
| MILLENDO THERAPEUTICS | Director Técnico/Científico/I+D | 12/07/2019 |
Shionogi, Inc.
 Shionogi, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes antibiotics | Corporate Officer/Principal | 01/10/2014 |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Corporate Officer/Principal | 01/01/2012 |
Novartis International AG
 Novartis International AG Pharmaceuticals: MajorHealth Technology Offers healthcare solutions | Corporate Officer/Principal | 01/01/2008 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 9 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Novartis International AG
Novartis International AG Pharmaceuticals: MajorHealth Technology Offers healthcare solutions | Health Technology |
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Millendo Therapeutics US, Inc.
 Millendo Therapeutics US, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company which develops a novel treatment for adrenal cancer | Health Technology |
Vanderbilt University
 Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Hawai'i at Hilo
 University of Hawai'i at Hilo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DBV Technologies SA
 DBV Technologies SA Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that focuses on changing the field of immunotherapy | Health Technology |
Shionogi, Inc.
Shionogi, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes antibiotics | Health Technology |
Millendo Therapeutics, Inc.
 Millendo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
